<DOC>
	<DOCNO>NCT00646516</DOCNO>
	<brief_summary>The purpose study determine whether treatment Symbicort 12 week improve lung function symptom adult adolescent asthma .</brief_summary>
	<brief_title>Gemini Symbicort pMDI</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Diagnosis asthma Baseline lung function test determine protocol . Required receive treatment inhaled corticosteroid and/or lung treatment specify protocol within timeframe dos specify protocol . Severe asthma Has require treatment noninhaled corticosteroid within previous 4 week , sensitivity drug specify protocol require treatment betablockers Had cancer within previous 5 year currently significant disease disorder judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>inhaled corticosteroid</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/formoterol</keyword>
	<keyword>budesonide</keyword>
</DOC>